BioPharma Consulting Services LLC (BPCS) provides strategic advice
and consulting services to the biotechnology and pharmaceutical
industry, primarily for small to medium sized biotechnology and pharmaceutical
companies.
With broad-based experience, a small dedicated team and a network
of experienced industry professionals, BPCS is well-positioned to provide
strategic and
operational expertise to companies facing challenges in the clinical
development, regulatory approval and commercialization of breakthrough
therapeutics.
Through its extensive multi-disciplinary network, BPCS has the
capability to support and manage almost all aspects of drug development.
BPCS can
assemble virtual drug development teams and assist in both outsourcing
and recruitment of internal staff. This has provided a number
of start-up companies an efficient and cost-effective approach to jump-starting
clinical
development even before recruiting internal staff. We encourage you to
contact
us to learn more about our services.
Our philosophy is that solid science throughout the development
process translates into better go/no go decisions, more collaborative
relationships with regulatory authorities and, ultimately, more successful
and cost-effective product development.
Located in the Seattle, Washington area, BioPharma Consulting Services LLC (BPCS) was founded in 2002 by Dr. Richard Stead in order to meet the growing needs of emerging and established companies developing biotechnology or pharmaceutical products. BPCS has the flexibility and responsiveness to meet specific requirements of small biotech companies. BPCS provides a range of services from shorter term, focused evaluation of clinical/regulatory strategy or in-licensing opportunities to longer term strategic and/or operational relationships.
BPCS has served clients in several therapeutic areas and has directed
the clinical development programs of a number of companies including interactions
with regulatory agencies as well as the initiation and refocusing of their
clinical trials programs. In addition, BPCS has been directly involved
in the management and fund-raising for smaller privately held companies.
Dr. Stead has served as Acting Chief Medical Officer and served on the
senior management for a number of emerging biotechnology companies. He
serves on the Board of Directors of Affimed Therapeutics AG, a privately
held biotechnology company based in Heidelberg, Germany that develops
next generation antibody therapeutics.
Strategic Planning
Clinical Development
Clinical Operations
Medical Affairs
Regulatory Affairs
Project Management
Biostatistics
Medical Writing
Preclinical Pharmacology
Toxicology
Manufacturing
Market Assessment &
Commercialization
Due Diligence
Hematology
Oncology
Neurology
Inflammatory Diseases
Nephrology
Endocrinology
Liver Disease
Cardiovascular Disease
Recombinant proteins and antibodies
Small molecular weight drugs
Immune Therapy
Cell Therapy
Gene Therapy
Medical Devices